Bayer stock trades at EUR 43.56, target is 40.0 percent higher

Published on 10/09/2026 at 15:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

JPMorgan kept its EUR 61.00 target and Overweight view on October 1, 2026. Bayer stock was at EUR 43.56 on October 9, 2026, up 1.18 percent.

Key points in brief

Bayer stock was trading at EUR 43.56 at Lang & Schwarz on October 9, 2026, plus 1.18 percent versus the prior close.
The price was 19.21 percent below its 52-week high of EUR 53.92, while market capitalization stood at EUR 42.6 billion.
JPMorgan maintained an Overweight rating and a EUR 61.00 target dated October 1, 2026.
Bayer is scheduled to publish third-quarter 2026 results on November 3, 2026.

Pop-Art-Comicpanel: begeisterter Forscher im weißen Kittel hält Reagenzglas triumphierend hoch, große Sprechblase mit DISCOVERY!, gelber Hintergrund mit roten Rasterpunkten, blauer Explosionsstern — Pop-Art-Comic im Lichtenstein-Stil: Forscher im Kittel hält jubilierend Reagenzglas hoch, Sprechblase DISCOVERY!, Illustration mit AI erstellt.

Bayer stock (ISIN DE000BAY0017) was trading at EUR 43.56 at Lang & Schwarz on October 9, 2026 at 3:33 p.m. CEST, up 1.18 percent during the session. The price target from JPMorgan stood 40.0 percent above the share price on October 1, 2026, when the bank maintained its Overweight rating and EUR 61.00 target, according to finanzen.net.

Price remains below yearly high

Bayer's Lang & Schwarz price was 19.21 percent below the 52-week high of EUR 53.92 and EUR 17.78 above the 52-week low of EUR 25.78 on October 9, 2026. The 52-week span places the stock in the upper half of its annual range, but the distance to the high remains material.

The bid was EUR 43.55 and the ask EUR 43.57 at 3:33 p.m. CEST. Trading volume on the primary German listing was 664,551 shares at 3:21 p.m. CEST, compared with an average volume of 2,088,798 shares.

Valuation and scheduled results

Bayer's market capitalization was EUR 42.6 billion on October 9, 2026. The trailing P/E ratio was minus 24.66, while the trailing dividend yield was 0.00 percent and is therefore not used as a valuation comparison.

JPMorgan's October 1, 2026 note kept the EUR 61.00 target and Overweight rating in place. The note said early expectations for the third quarter could be too high because of timing effects in the agricultural business, while full-year estimates were expected to remain broadly unchanged, according to finanzen.net.

Bayer is scheduled to publish its third-quarter 2026 results on November 3, 2026 at 7:30 a.m. CET, followed by an investor video call at 2:00 p.m. CET, according to Bayer. The date gives the stock a defined calendar point after the current trading session.

Comparison with peers

Bayer: plus 1.18 percent, P/E minus 24.66, market capitalization EUR 42.6 billion
BASF (Xetra, EUR): minus 0.1 percent, P/E 7.77, market capitalization EUR 44.6 billion
Merck KGaA (Xetra, EUR): plus 1.7 percent, P/E 25.31, market capitalization EUR 59.9 billion

Next price reference

Bayer was trading at EUR 43.56 at Lang & Schwarz on October 9, 2026 at 3:33 p.m. CEST, versus the prior close of EUR 43.05 on October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.